N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

Clinical trial NCT01474395 · UNKNOWN

Trial details

NCT number: NCT01474395
Sponsor: Nathan Kline Institute for Psychiatric Research
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2012-03-01
Primary completion: 2013-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.